| 000 | 01524 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517001044.0 | ||
| 264 | 0 | _c20150528 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1471-2407 | ||
| 024 | 7 |
_a10.1186/1471-2407-14-780 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaw, Robyn P M | |
| 245 | 0 | 0 |
_aAdjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D). _h[electronic resource] |
| 260 |
_bBMC cancer _cOct 2014 |
||
| 300 |
_a780 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aSkin Neoplasms |
| 650 | 0 | 4 |
_aVitamin D _xadministration & dosage |
| 650 | 0 | 4 | _aMelanoma, Cutaneous Malignant |
| 700 | 1 | _aArmstrong, Bruce K | |
| 700 | 1 | _aMason, Rebecca S | |
| 700 | 1 | _aMorton, Rachael L | |
| 700 | 1 | _aShannon, Kerwin F | |
| 700 | 1 | _aSpillane, Andrew J | |
| 700 | 1 | _aStretch, Jonathan R | |
| 700 | 1 | _aThompson, John F | |
| 773 | 0 |
_tBMC cancer _gvol. 14 _gp. 780 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2407-14-780 _zAvailable from publisher's website |
| 999 |
_c24304750 _d24304750 |
||